If you live with endometriosis you have probably had the experience of describing your symptoms and watching them get filed under something simpler. Alloy is one of the few providers here where the intake does not do that. Hormone-specialist physicians take a full endocrine and gynecologic history, and that history goes on to shape the care.
That is the whole reason it rates near the top of the Charter. Not because Alloy treats endometriosis — no provider on this page does, and any provider suggesting otherwise would be worth walking away from — but because it is built to hear the rest of your picture instead of asking you to set it aside.
Here is how Alloy Women's Health reads against each promise of the Whole-Woman Charter. Each promise is marked none, partial or strong; price is shown but is never part of the rating. GLP-1 medications are not a treatment for endometriosis.
At $199 a month with 503A compounding, Alloy is priced below several providers offering considerably less clinical attention. Taking a gynecologic history matters practically, not just emotionally: it means the clinician adjusting your dose knows about your pain pattern and your hormonal treatment, so decisions are made with that in view rather than around it. The first two Charter rows both score strong for this reason.
Two rows sit at partial — lasting care and honest cost. Alloy publishes no dedicated maintenance or step-down protocol, so the phase after the weight moves is not mapped out in advance. Endometriosis is a condition you manage over decades, and a plan that ends when the losing stops leaves the longest stretch unplanned. Worth raising directly before you enrol rather than discovering later.
Put these to Alloy Women's Health in writing, and keep the reply.
Alloy rates highly on this Charter because it is built to see you whole and it is honest about being a hormone practice rather than an endometriosis service. The gap is the long game — nothing is published about what happens after. Ask, and if the answer is solid this is one of the strongest options here at the price.
What is above comes from what this provider chooses to publish, and providers revise their terms without saying so — treat it as a starting point and check it yourself. Havelle is editorial, not clinical: none of this is medical advice, and GLP-1 medications are not a treatment for endometriosis.